Abstract
Catheter ablation of the slow pathway in patients with atrioventricular nodal reentrant tachycardia (AVNRT) is mainly performed using anatomical landmarks. We sought to see whether a new ablation catheter equipped with mini-electrodes may facilitate the mapping of slow pathway potentials for AVNRT ablation. We prospectively included patients referred for AVNRT in our center. Mapping and ablation were performed using an irrigated catheter equipped with 3 insulated mini-electrodes on the distal tip. Thirteen consecutive patients were included (85% female, median age 46 years). Slow pathway potentials could be identified in 77% of cases on mini-electrode bipolar tracings, versus 15% on conventional bipolar tracings (p = 0.0009). At the end of the procedure, double potentials on the ablation line were identified in all patients, only on mini-electrode bipolar tracings. Following ablation, an interval separating double potentials in sinus rhythm ≥15% of baseline tachycardia cycle length was associated with non-inducibility in all patients (p < 0.0001). No recurrence occurred during 1 year of follow-up. The use of mini-electrodes may help target slow pathway potentials during AVNRT ablation. Identification of sufficiently split double potentials on the ablation line might represent an electrophysiological endpoint in these patients.
Highlights
Academic Editors: Christian Sohns and Philipp SommerReceived: 13 December 2021Accepted: 4 January 2022Published: 5 January 2022Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.Atrioventricular (AV) nodal reentrant tachycardia (AVNRT) is the most frequent junctional tachycardia
Mapping was performed anteriorly to the coronary sinus ostium, and radiofrequency energy was applied during 60 s where slow potentials could be identified
A total of 13 consecutive patients addressed for ablation of symptomatic atrioventricular nodal reentrant tachycardia (AVNRT) were prospectively included
Summary
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Catheter ablation of the slow pathway can be recommended in symptomatic patients as it is an efficient and permanent therapy with a >90% success rate [1]. Discrete sharp and discrete potentials initially described by Jackman and Haissaguerre, respectively, are not routinely used to target the slow pathway [2,3]. These signals are challenging to identify, and their pathophysiological significance remains unclear.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.